Arginine Vasopressin vs IGF-2

Head-to-head comparison of Arginine Vasopressin (8-Arginine Vasopressin) and IGF-2 (Insulin-Like Growth Factor II) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyArginine VasopressinIGF-2
CategoryCognitive EnhancementCognitive Enhancement
Full Name8-Arginine VasopressinInsulin-Like Growth Factor II
Molecular Weight1084.23 Da7467 Da
Half-Life10-20 minutes6-10 minutes
Amino Acids967 aa
Typical Dose10-40 IU intranasal research range1-10 µg preclinical range
RouteIntranasal/SubcutaneousIntranasal
Purity≥98%≥98%
Studies Count1001200
Research StatusClinicalPre-clinical

Arginine Vasopressin Benefits

  • memory consolidation
  • recall support
  • arousal-linked learning
  • social cognition

IGF-2 Benefits

  • memory consolidation
  • hippocampal plasticity
  • synaptic repair
  • neuroprotection

Arginine Vasopressin Dosing

intranasal research dosing|10-40 IU per dose in studies|single or repeated administration

IGF-2 Dosing

0.1-1 µg ICV in rodents|1-10 µg intrahippocampal in preclinical work|acute post-training protocols

Arginine Vasopressin Side Effects

  • blood pressure elevation
  • headache
  • hyponatremia

IGF-2 Side Effects

  • hypoglycemia risk
  • edema
  • insulin-like systemic effects

Research Overview

Arginine Vasopressin

Animal and human studies indicate vasopressin can modulate hippocampal and limbic circuits involved in learning and memory. The effect size is context dependent, and results vary by dose, route, and baseline cognitive state.

IGF-2

IGF-2 has strong preclinical evidence for improving memory formation and supporting synaptic changes tied to learning. It also shows neuroprotective and repair-related effects in models of injury and neurodegeneration.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Arginine Vasopressin stacks with:

gpenoopeptdesmopressin

IGF-2 stacks with:

BDNFciticolinealpha-gpc
nonapeptidememoryneuropeptidehippocampusgrowth-factorplasticity